Search Results 601-610 of 13491 for monoclonal antibody

1. A Study To Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) For Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

2. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

3. Oncology (Medical) - Clinical trials

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

4. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...

5. Medical Research & Education - Mayo Clinic News Network

   Latest stories · Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image · Strong immune response underlies acute kidney injury related ...

6. Wilms Tumor Clinical Trials - Mayo Clinic Research

   Antibody-drug conjugates, such as lorvotuzumab mertansine, are ... Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways.

7. Clinical trials - Oncology (Medical)

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

8. Pozelimab-bbfg (intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

   This medicine is a monoclonal antibody that works on the immune system. This medicine is to be given only by or under the direct supervision of your doctor ...

9. A Study To Evaluate Pembrolizumab And Dasatinib, Imatinib Mesylate, Or Nilotinib In Treating Patients With Chronic Myeloid Leukemia And Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Patient must not have received a prior anti-cancer monoclonal antibody (mAb) ...

10. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...